Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

QTRX

STRONG SELL

Quanterix Corporation · Healthcare · United States · $173M · Avg Vol: $3M/d

20
StockRank
Get insider-trade alerts
Q
32
V
41
M
32
P/E (TTM)
ROE
-34.8%
D/E
0.1x
Dividend %

COMPANY DESCRIPTION

Quanterix Corporation develops and commercializes ultra-sensitive digital immunoassay platforms, Simoa technology, used for detecting and quantifying biomarkers at extremely low concentrations for early disease detection and research. Its proprietary Simoa technology offers significantly higher sensitivity than conventional immunoassays, providing a strong technological advantage in biomarker detection and creating high switching costs. Quanterix is a leader in ultra-sensitive biomarker detection, positioned at the forefront of precision medicine and early diagnostics.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue105.0M121.1M135.4M138.7M9.7%145.0M169.6M188.4M16.6%
EPS-2.61-0.75-1.00-2.51-2.37-1.23-1.36
Shares37.3M38.0M38.5M46.7M+25.4%47.1M
Debt44.1M41.5M37.4M37.2M-5.5%35.3M
Equity357.9M350.0M330.0M295.7M-6.2%
Op CF-48.6M-18.8M-35.2M-77.2M-81.5M
Inv CF-11.1M-148.5M-82.3M50.2M
Fin CF2.3M2.7M0.5M-0.7M
Loading 1Y...
PRICE (1Y)+21.1%
2.883.303.714.134.54Jun 11Jul 6Jul 24
SMA 50SMA 200
Close
$3.67
RSI (14)
33.9
52W High
$8.77
From 52W High
0.4%

SCORE BREAKDOWN

Quality
32
ROIC
-31.9%23.4
ROE
-34.8%24.4
GP/Assets
15.7%38.0
Op. Margin
-59.1%20.3
FCF/Assets
-5.2%34.9
Piotroski
25.5
Int. Cover
N/A
D/E Ratio
0.13x59.8
Current Ratio
3.72x62.1
Value
41
P/E (TTM)
N/A
EV/EBITDA
-1.9x25.0
P/FCF
N/A
P/B
0.7x93.5
P/S
1.3x79.4
Div Yield
N/A
Momentum
32
52W High %
42%17.3
RS 6M
-57%12.5
SMA 50/200
0.69x7.5
EPS Rev 4W
0.0%62.5
EPS Rev 12W
+28.8%95.0
EPS Improve
+43%50.8
Q Growth
N/A

FUNDAMENTALS

Market Cap
$173M
P/E (Forward)
-2.9x
Gross Margin
45.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of QTRX are excluded.

TickerCompanyMkt CapStockRankSignal
QTRXQuanterix Corporation(you)$173M20STRONG SELL
RXSTRxSight, Inc.$215M22SELL
AVH.AXAVITA Medical, Inc.$115M19STRONG SELL
QSIQuantum-Si incorporated$168M11STRONG SELL
SGHTSight Sciences, Inc.$267M19STRONG SELL
LUCDLucid Diagnostics Inc.$173M9STRONG SELL
OWLTOwlet, Inc.$153M11STRONG SELL
TLSITriSalus Life Sciences, Inc.$259M16STRONG SELL
STIMNeuronetics, Inc.$120M15STRONG SELL
CVRXCVRx, Inc.$126M12STRONG SELL

Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.7%

Quanterix Corporation (QTRX) — Stock Score Summary

Quanterix Corporation (QTRX) has a MoatMap StockRank of 20/100 based on Quality (32/100), Value (41/100), and Momentum (32/100) factor scores. The current signal is STRONG SELL.

Quanterix Corporation develops and commercializes ultra-sensitive digital immunoassay platforms, Simoa technology, used for detecting and quantifying biomarkers at extremely low concentrations for early disease detection and research. Its proprietary Simoa technology offers significantly higher sensitivity than conventional immunoassays, providing a strong technological advantage in biomarker detection and creating high switching costs. Quanterix is a leader in ultra-sensitive biomarker detection, positioned at the forefront of precision medicine and early diagnostics.

Key Financial Metrics

Price$3.67
Market Cap$173M
P/E (Forward)-2.87
Price/Book0.65
Return on Equity-34.8%
Return on Invested Capital-31.9%
Debt/Equity0.13x
Gross Margin45.3%
Operating Margin-59.1%
Revenue Growth20.1%
Free Cash Flow$-22M

Quanterix Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Quanterix Corporation’s (QTRX) StockRank?
MoatMap’s StockRank for Quanterix Corporation (QTRX) is 20/100, with a Strong Sell signal. It is a composite of Quality (32), Value (41), and Momentum (32) factor ranks across MoatMap’s 20,000+ stock universe.
Does Quanterix Corporation have an economic moat?
Quanterix Corporation (QTRX) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Quanterix Corporation a buy, hold, or sell?
MoatMap’s current signal for Quanterix Corporation (QTRX) is Strong Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Quanterix Corporation in?
Quanterix Corporation (QTRX) operates in the Healthcare sector, specifically the Medical Devices industry (United States).